BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16253029)

  • 1. The Italian quality control scheme for crossmatching procedures and HLA sera screening: the 2002 pilot study.
    Conca R; Praticò-Barbato L; Dall'Omo AM; Amoroso A
    Arch Pathol Lab Med; 2005 Nov; 129(11):1470-5. PubMed ID: 16253029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress report on the ASHI/CAP Proficiency Survey Program in Histocompatibility Testing. I. HLA-A,B,C typing, antibody screening, and lymphocytotoxicity crossmatching. American Society for Histocompatibility and Immunogenetics. College of American Pathologists.
    Marrari M; Duquesnoy RJ
    Hum Immunol; 1994 Feb; 39(2):87-95. PubMed ID: 8175387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multilaboratory evaluation of serum analysis for HLA antibody and crossmatch reactivity by lymphocytotoxicity methods.
    Duquesnoy RJ; Marrari M
    Arch Pathol Lab Med; 2003 Feb; 127(2):149-56. PubMed ID: 12562227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quality control program for crossmatching procedures for solid organ transplantation. The participating laboratories of the Australasian and South Asian Tissue Typing Association.
    Howden AJ; Sayer DC; Bennett G; Smith LK; Christiansen FT
    Hum Immunol; 2000 Apr; 61(4):419-24. PubMed ID: 10715519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress report on the ASHI/CAP Proficiency Survey Program in Histocompatibility Testing. II. HLA-DR, DQ serologic typing, antibody identification, and B-cell crossmatching. American Society for Histocompatibility of Immunogenetics. College of American Pathologists.
    Duquesnoy RJ; Marrari M
    Hum Immunol; 1994 Feb; 39(2):96-105. PubMed ID: 8175388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of the HLA proficiency testing for Central and East Europe.
    Bogunia-Kubik K; Lange A
    Int J Immunogenet; 2008 Aug; 35(4-5):409-16. PubMed ID: 18976448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of immunogenetics interlaboratory comparisons' success rates. External quality assurance system of the Spanish Society for Immunology GECLID-SEI.
    Martín MC
    Front Genet; 2024; 15():1268728. PubMed ID: 38746054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Human leukocyte antigen typing proficiency surveys in Korea, 2005-2006].
    Kim MH; Choi SE; Oh HB
    Korean J Lab Med; 2007 Dec; 27(6):442-50. PubMed ID: 18160835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quality control in an immunohematology laboratory in the Croatian Transfusion Service].
    Sarlija D; Balija M; Bosanac I; Hundrić-Haspl Z; Tomicić M; Grgicević D
    Lijec Vjesn; 1995; 117(1-2):19-23. PubMed ID: 7651064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress report on the ASHI/CAP Histocompatibility Survey Program, 1981-1986.
    Duquesnoy RJ; Marrari M; Walker RH
    Arch Pathol Lab Med; 1987 Dec; 111(12):1101-5. PubMed ID: 3675146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accreditation of histocompatibility and immunogenetics laboratories: Achievements and future prospects from the European Federation for Immunogenetics Accreditation Programme.
    Harmer A; Mascaretti L; Petershofen E
    HLA; 2018 May; ():. PubMed ID: 29722176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relevance of proficiency testing for laboratories involved in cadaveric organ transplantation and its consequences for graft survival.
    Doxiadis II; Witvliet M; Verduyn W; de Lange P; Tanke J; Schreuder GM; Persijn GG; Claas FH
    Clin Transpl; 2000; ():99-103. PubMed ID: 11512364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. North American pretransfusion testing practices, 2001-2004: results from the College of American Pathologists Interlaboratory Comparison Program survey data, 2001-2004.
    Shulman IA; Maffei LM; Downes KA
    Arch Pathol Lab Med; 2005 Aug; 129(8):984-9. PubMed ID: 16048410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [National quality control of serologic HLA typing].
    Quintieri F; Pugliese O; Mariani M
    Ann Ist Super Sanita; 1999; 35(1):41-4. PubMed ID: 10645643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the performance of virtual crossmatch results by correlating with nationally-performed physical crossmatches: Obtaining additional value from proficiency testing activities.
    Wrenn SM; Marroquin CE; Hain DS; Harm SK; Pineda JA; Hammond PB; Shah DH; Hillyard SE; Fung MK
    Hum Immunol; 2018 Aug; 79(8):602-609. PubMed ID: 29864460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EFI region 8 Balkan external proficiency testing for HLA typing: Results of 15 years.
    Kekik Cinar C; Usta Akgul S; Temurhan S; Senturk Ciftci H; Ogret Y; Karahan GE; Oguz FS
    Int J Immunogenet; 2020 Apr; 47(2):158-162. PubMed ID: 31872562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [National quality control of genomic HLA typing].
    Ferrara GB
    Ann Ist Super Sanita; 1999; 35(1):45-9. PubMed ID: 10645644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The omission of the "wet" pre-transplant crossmatch in renal transplant centres in Scotland.
    Turner D; Battle R; Akbarzad-Yousefi A; Little AM
    HLA; 2019 Jul; 94(1):3-10. PubMed ID: 31025501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Organization of the work of the All-Union Bank of Histotyping Standards].
    Nikolenko VN; Berkos AS; Erokhina LV; Serova LD
    Gematol Transfuziol; 1987 Dec; 32(12):42-5. PubMed ID: 3443280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.